JBC Advanced Peptides, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tamm, A.
Right arrow Articles by Schmidt, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tamm, A.
Right arrow Articles by Schmidt, R. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 7, Issue of February 16, 1996 pp. 3659-3666
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The IgG Binding Site of Human FcRIIIB Receptor Involves CC` and FG Loops of the Membrane-proximal Domain

(Received for publication, September 25, 1995)

Anu Tamm Alexander Kister K. Ulrich Nolte J. Engelbert Gessner Reinhold E. Schmidt

Fc receptors for the Fc part of IgG are the mediators for antibody effector functions. FcRIII and FcRII are low affinity receptors that, through the interaction with immune complexes, initiate a variety of immunological responses, such as phagocytosis, antibody-dependent cellular cytotoxicity, and release of inflammatory mediators. We set out to define the IgG binding site on human FcRIII. We assumed that potential beta-turns in Ig-like domains are the most probable determinants for ligand binding, and chimeric FcRIIIB/FcRI receptors as well as single residue mutants were constructed in these regions of FcRIIIB. Substitution of four amino acids in the membrane-proximal domain (Gln, Arg, Lys, Val) resulted in decreased binding of human IgG1. Lys and Val were found also to be crucial for the interaction with the IgG-binding inhibitory monoclonal antibody 3G8. In a putative three-dimensional model constructed in this study, these residues map on the CC` loop (Gln), on F beta-sheet (Arg), and on the FG loop (Lys, Val). Our data are consistent with the study about human FcRII (Hulett, M. D., Witort, E., Brinkworth, R. I., McKenzie, I. F. C., and Hogarth, P. M.(1994) J. Biol. Chem. 269, 15287-15293), suggesting that common structural determinants, i.e. FG loop or the GFC surface of the membrane-proximal domain, can be involved in interactions with IgG by both low affinity receptor classes FcRII and FcRIII.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Y. Oshima, A. Fujimura, G. Cartron, L. Dacheux, G. Salles, P. Solal-Celigny, P. Bardos, P. Colombat, and H. Watier
Implication for how the single nucleotide polymorphism (SNP) of Fc receptor, Fcgamma RIIIa alters the interaction with anti-CD20 monoclonal antibody
Blood, May 29, 2002; 99(12): 4649 - 4650.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. E. Chesla, P. Li, S. Nagarajan, P. Selvaraj, and C. Zhu
The Membrane Anchor Influences Ligand Binding Two-dimensional Kinetic Rates and Three-dimensional Affinity of Fcgamma RIII (CD16)
J. Biol. Chem., March 31, 2000; 275(14): 10235 - 10246.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Craig Morton, G. van Zandbergen, C. van Kooten, C. J. Howard, J. G. J. van de Winkel, and P. Brandtzaeg
Immunoglobulin-binding Sites of Human Fcalpha RI (CD89) and Bovine Fcgamma 2R Are Located in their Membrane-distal Extracellular Domains
J. Exp. Med., June 7, 1999; 189(11): 1715 - 1722.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. D. Hulett, R. I. Brinkworth, I. F. C. McKenzie, and P. M. Hogarth
Fine Structure Analysis of Interaction of Fcepsilon RI with IgE
J. Biol. Chem., May 7, 1999; 274(19): 13345 - 13352.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Meyer, C. Schiller, J. Westermann, S. Izui, W. L. W. Hazenbos, J. S. Verbeek, R. E. Schmidt, and J. E. Gessner
Fcgamma RIII (CD16)-Deficient Mice Show IgG Isotype-Dependent Protection to Experimental Autoimmune Hemolytic Anemia
Blood, December 1, 1998; 92(11): 3997 - 4002.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. R. Koene, M. Kleijer, J. Algra, D. Roos, A. E.G.Kr. von dem Borne, and M. de Haas
Fcgamma RIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell Fcgamma RIIIa, Independently of the Fcgamma RIIIa-48L/R/H Phenotype
Blood, August 1, 1997; 90(3): 1109 - 1114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Gessner, T. Grussenmeyer, M. Dumbsky, and R. E. Schmidt
Separate Promoters from Proximal and Medial Control Regions Contribute to the Natural Killer Cell-specific Transcription of the Human Fcgamma RIII-A (CD16-A) Receptor Gene
J. Biol. Chem., November 29, 1996; 271(48): 30755 - 30764.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. L. Shields, A. K. Namenuk, K. Hong, Y. G. Meng, J. Rae, J. Briggs, D. Xie, J. Lai, A. Stadlen, B. Li, et al.
High Resolution Mapping of the Binding Site on Human IgG1 for Fcgamma RI, Fcgamma RII, Fcgamma RIII, and FcRn and Design of IgG1 Variants with Improved Binding to the Fcgamma R
J. Biol. Chem., February 23, 2001; 276(9): 6591 - 6604.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Radaev, S. Motyka, W.-H. Fridman, C. Sautes-Fridman, and P. D. Sun
The Structure of a Human Type III Fcgamma Receptor in Complex with Fc
J. Biol. Chem., May 4, 2001; 276(19): 16469 - 16477.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.